Kinetic Study of the Effect of Heparin on the Amidase Activity of Trypsin, Plasmin and Urokinase

Summary

It was found that the effect of heparin on the amidase activity of urokinase (E C 3.4.21.31), plasmin (E C 3.4.21.7) and trypsin (E C 3.4.21.4) depended on the substrate used. No effect of heparin on the amidase activity of urokinase and trypsin was observed when Pyro Glu-Gly-Arg-p-nitroanilide (S-2444) and α-N-acetyl-L-lysine-p-nitroanilide (ALNA) were used as substrates. Heparin acted as a uncompetitive inhibitor of trypsin (K_i = 1.2×10^-6 M), plasmin (K_i = 4.9×10^-6 M) and urokinase (K_i = l.0×10^-7 M) when Bz-Phe-Val-Arg-p-nitroanilide (S-2160), H-D-Val-Leu-Lys-p-nitroanilide (S-2251) and plasminogen, respectively, were used as substrates. These results, as well as the data obtained by studying the effect of the simultaneous presence of heparin and competitive inhibitors suggest that although heparin is not bound at the active center of these enzymes, it may influence the effectivity of catalysis.

Keywords

Uncompetitive inhibition - Heparin - Amidase activity - Trypsin-plasmin-urokinase

• References

• 1 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
• 2 Longas MA, Ferguson WS, Finlay T. Studies on the interaction of heparin with thrombin antithrombin and other plasma proteins. Arch Biochem and Biophys 1980; 200: 595-602
• 3 Griffith MJ, Kingdon HS, Lundblad R. The interaction of heparin with human a-thrombin: effect on the hydrolysis of anilide tripeptide substrates. Arch Biochem Biophys 1979; 195: 378-384
• 4 Griffith MJ. Kinetic analysis of the heparin enhanced antithrombin III-thrombin reaction. J Biol Chem 1979; 254: 12044-12049
• 5 Machovitch R. Mechanism of action of heparin through thrombin on blood coagulation. Biochim Biophys Acta 1975; 412: 13-17
• 6 Holmer E, Soderstrom G, Andersson LO. Studies on the mechanism of the rate-enhancing effect of heparin on the thrombin-anti thrombin reaction. Eur J Biochem 1979; 93: 1-5
• 7 Kohn S, Sakurama S, Morioka T, Ito Y, Yasukouchi T, Nakagawa S. The interaction between heparin and plasmin on amidolysis. Thromb Haemostas 1979; 42: 1261-1275
• 8 Murano G, Aronson D, Williams L, Brown L. The inhibition of high and low molecular weight urokinase in plasma. Blood 1980; 1; 55: 430-436
• 9 Nakajima K, Powers J, Ashe B, Zimmermann M. Mapping of the extended substrate binding site of cathepsin G and human leucocyte elastase. Studies with peptide substrates related to dj-protease inhibitor reactive site. J Biol Chem 1979; 254: 4027-4032
• 10 Collen D, Lijnen HR, DeCock F, Durieux JP, Loffet A. Kinetic properties of tripeptide lysyl chloromethyl ketones and lysyl-p-nitroanilide derivatives towards trypsin-like serine proteases. Biochim Biophys Acta 1980; 165: 158-166
• 11 Claeson G, Aurell L, Friberger P, Gustavsson S, Karlsson G. Designing of peptide substrates. Different approaches exemplified by new chromogenic substrates for kallikreins and urokinase. Haemostasis 1978; 07: 62-68
• 12 Wohl RC, Summaria L, Robbins KC. Kinetics of activation of human plasminogen by different activator species at pH 7.4 and 37° C. J Biol Chem 1980; 255: 2005-2013
• 13 Chase T, Shaw E. Titration of trypsin plasmin and thrombin with p-nitrophenyl p’-guanidinobenzoate HC1. In: Methods in Enzymol. 1970. 19. 20-27
• 14 Yomtova V, Tchorbanov B, Novkova S, Blagoev B. Highly purified urokinase from human urine. J Appl Biochem 1980; 2: 1-6
• 15 Soberano ME, Ong EB, Johnson AJ, Levy M, Schoellmann G. Purification and characterization of two forms of urokinase. Biochim Biophys Acta 1976; 445: 763-773
• 16 McClintock DK, Englert ME, Dzobkovski C, Snedeker EH, Bell PH. Two distinct pathways of the Stk-mediated activation of highly purified human plasminogen. Biochem 1974; 13: 5334-5344
• 17 Friberger P. Methods for the determination of plasmin, antiplasmin and plasminogen by means of the substrate S-2251. Abstract XXXIII of the Annual General Meeting of the Swedish Society of Med Sd. 1976
• 18 Deutsch DG, Mettz ET. Plasminogen: purification from human plasms by affinity chromatography. Science 1970; 170: 1095-1096
• 19 Wiman B, Wallen P. Structural relationship between “glutamic acid” and lysine forms of human plasminogen and their interaction with the NH₂-terminal activation peptide as studied by affinity chromatography. Eur J Biochem 1975; 50: 489-494
• 20 Petkov D, Christova E, Karadjova M. Amidase activity of urokinase. Thrombos Diathes Haemorrh 1973; 29: 276-285
• 21 Takada K, Sakakibara S, Kato H, Goto T, Iwanaga S. Synthesis of Bz-Phe(p-NOj)-Val-Arg-p NA and its specificity to thrombin like enzymes: Similarity of a commercial product S-2160 to the nitrated compound. Thromb Res 1980; 20: 533-542
• 22 Segel IH. Integrated form of the Henri-Michaelis-Menten equation. In: Enzyme Kinetics. pp. 54-64 Wiley-Interscience; New York: 1975
• 23 Segel IH. Uncompetitive inhibition. In: Enzyme Kinetics. pp. 136-143 Wiley-Interscience; New York: 1975
• 24 Griffith MJ, Kingdon HS, Lundblad RL. Hydrolysis of N-Bz-L-Phe-L-Val-L-Arg-p-nitroanilide by human alpha thrombin in the presence of heparin. Thromb Res 1980; 17: 83-90
• 25 Griffith MJ, Beavers G, Kingdon HS, Lundblad RL. Effect of monovalent cations on the heparin-enhanced antithrombin III thrombin reaction. Thromb Res 1980; 17: 29-39
• 26 Segel IH. Multiple Inhibition analysis. In: Enzyme Kinetics. pp. 474-504 Wiley-Interscience; New-York: 1975
• 27 Yonetani T, Theorell H. Studies on liver alcohol dehydrogenase complexes III. Multiple inhibition kinetics in the presence of two competitive inhibitors. Arch Biochem Biophys 1964; 106: 243-251
• 28 Krieger M, Kay LM, Stroud RM. Structure and specific binding of ttypsin. J Mol Biol 1974; 83: 209-230
• 29 Abildgaard U. Inhibition of the fibrinogen-thrombin reaction by heparin and purified cofactor. Scand J Haematol 1968; 05: 432-439